Thoracic sarcoidosis is the most common form of sarcoidosis, encompassing a
heterogeneous group of patients with a wide range of clinical features and associated …

Sarcoidosis is a multisystem, granulomatous disease that most often affects the lungs. The
clinical course is highly variable; many patients undergo spontaneous remission, but up to a …

Sarcoidosis is an immune-mediated disorder. Its immunopathology has been steadily
mapped out over the past few decades. Despite this, the underpinning mechanisms for …

Despite more than a century of research, the causative agent (s) in sarcoidosis, a
heterogeneous granulomatous disorder mainly affecting the lungs, remain (s) elusive …

Research over the past decade has advanced our understanding of the pathogenesis of
sarcoidosis and provided new insights into potential causes of this disease. It is important to …

Sarcoidosis continues to be a disease of research interest because of its complicated
immune mechanisms and elusive etiology. So far, it has been established that …

Advancements in the understanding of sarcoidosis support its consideration as an
autoimmune disease. Sarcoidosis patients carry a higher risk of comorbid autoimmune …

Sarcoidosis is a disorder of unknown etiology. It is a systemic disease, frequently involving
the lungs, skin, eyes, and lymph nodes. It is characterized by formation of noncaseating …

This is an update on sarcoidosis, focusing on etiology, diagnosis, and treatment. In the area
of etiopathogenesis, we now have a better understanding of the immune response that …

Sarcoidosis, a systemic granulomatous disease of undetermined etiology, is characterized
by a variable clinical presentation and course. During the past decade, advances have been …